InflaRx (IFRX) Inventory (2023 - 2025)
InflaRx (IFRX) posted Inventory of $5.9 million for Q3 2025, up 3.95% sequentially from $5.7 million in Q2 2025, and down 44.45% YoY from $10.7 million in Q3 2024.
InflaRx (IFRX) Inventory (2023 - 2025) Analysis & Trends
InflaRx has reported Inventory for 3 years, with the latest figure at $5.9 million in Q3 2025.
- Quarterly Inventory fell 44.45% year-over-year to $5.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $5.9 million (down 44.45% YoY) and the FY2024 annual result came in at $7.5 million, down 39.29% from the prior year.
- Inventory improved to $5.9 million in Q3 2025 per IFRX's latest filing, from $5.7 million in the prior quarter.
- Over five years, Inventory peaked at $12.2 million in Q4 2023 and troughed at $630166.0 in Q2 2023.
- A 3-year average of $7.4 million and a median of $7.3 million in 2025 frame the typical range for Inventory.
- The sharpest annual moves came in 2024 and 2025: Inventory soared 1548.1% in 2024, then plunged 45.09% in 2025.
- Over 3 years, Inventory stood at $12.2 million in 2023, then slumped by 39.74% to $7.4 million in 2024, then decreased by 19.57% to $5.9 million in 2025.
- According to Business Quant data, Inventory over the past three periods registered $5.9 million, $5.7 million, and $7.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Dec 31, 2024 | 7.37 Mn |
| Sep 30, 2024 | 10.67 Mn |
| Jun 30, 2024 | 10.39 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 12.23 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 630,165.99 |